No More Licensing: NY Biotech Company Zentalis Raises US$20M To Fund Chinese Venture
The joint venture Zentera will develop and commercialize Zentalis’ pipeline candidates in China New York-headquartered clinical-stage biopharmaceutical company Zentalis Pharmaceuticals has closed a Series A round at $20 million to fund the establishment of joint venture Zentera Therapeutics, the company announced in a statement earlier this week. Zentalis will hold majority stakes in Shanghai-headquartered biopharma […]
No More Licensing: NY Biotech Company Zentalis Raises US$20M To Fund Chinese Venture Read More »
The joint venture Zentera will develop and commercialize Zentalis’ pipeline candidates in China New York-headquartered clinical-stage biopharmaceutical company Zentalis Pharmaceuticals has closed a Series A round at $20 million to fund the establishment of joint venture Zentera Therapeutics, the company announced in a statement earlier this week. Zentalis will hold majority stakes in Shanghai-headquartered biopharma




